HOME /

Publications

Search
Author [ Title(Desc)] Type Year
D
Gamble J-M, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR. Diabetes Research and Clinical Practice. The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85039789313&partnerID=MN8TOARS
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, et al. Diabetic Medicine. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85129462097&partnerID=MN8TOARS
Abu-Ashour W, Chibrikova L, Midodzi WK, Twells LK, Gamble J-M. Diabetic Medicine. Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&partnerID=MN8TOARS
Abu-Ashour W, Chibrikova L, Midodzi WK, Twells LK, Gamble J-M. Diabetic Medicine. Factors associated with early insulin initiation in Type 2 diabetes: A Canadian cross-sectional study [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&partnerID=MN8TOARS
Eurich DT, Gamble JM, Marrie TJ, Majumdar SR. Diabetologia. Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia [Internet]. 2010;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-77949264220&partnerID=MN8TOARS
Dose response of sodium glucose cotransporter-2 inhibitors in relation to urinary tract infections: a systematic review and network meta-analysis of randomized controlled trials. CMAJ Open [Internet]. 2018;Available from: http://cmajopen.ca/content/6/4/E594.full Donnan et al. CMAJOpen 2018.pdf
Gamble J-M, Alkabbani W. Drug Safety. Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data” [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85152556353&partnerID=MN8TOARS
Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble J-M. Drug Safety. Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85125655701&partnerID=MN8TOARS
Gamble J-M, Alkabbani W. Drug Safety. Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.” [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85132201172&partnerID=MN8TOARS
Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble J-M. Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data. DRUG SAFETY. 2022;45:287-295.
Anand K, Sketris I, Zhang Y, Levy A, Gamble J-M. Drugs - Real World Outcomes. The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85047232099&partnerID=MN8TOARS
E
Pelletier R, Ng K, Alkabbani W, Labib Y, Mourad N, Gamble J-M. Endocrinology, Diabetes and Metabolism. The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85084999654&partnerID=MN8TOARS
F
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MWasem, et al. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus. DIABETIC MEDICINE. 2022;39:e14858.
H
Gamble J-M, Eurich DT, Johnson JA. Healthcare Policy. A comparison of drug coverage in Alberta before and after the introduction of the national common drug review process [Internet]. 2010;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-79851495266&partnerID=MN8TOARS
I
Shakeri A, Dolovich L, MacCallum L, Gamble J-M, Zhou L, Cadarette SM. Impact of the 2016 Policy Change on the Delivery of MedsCheck Services in Ontario: An Interrupted Time-Series Analysis. Pharmacy (Basel). 2019;7(3).
Amegadzie JE, Gamble J-M, Farrell J, Gao Z. International Journal of COPD. Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85131104214&partnerID=MN8TOARS
Amegadzie JE, Gamble J-M, Farrell J, Gao Z. International Journal of COPD. Gender differences in inhaled pharmacotherapy utilization in patients with obstructive airway diseases (OADS): A population-based study [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85092135919&partnerID=MN8TOARS
Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble J-M. International Journal of Epidemiology. Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85147424628&partnerID=MN8TOARS
J
Alwashmi MF, Fitzpatrick B, Farrell J, Gamble J-M, Davis E, van Nguyen H, et al. JMIR mHealth and uHealth. Perceptions of patients regarding mobile health interventions for the management of chronic obstructive pulmonary disease: Mixed methods study [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85088678572&partnerID=MN8TOARS
Alwashmi MF, Fitzpatrick B, Davis E, Gamble J-M, Farrell J, Hawboldt J. JMIR mHealth and uHealth. Perceptions of health care providers regarding a mobile health intervention to manage chronic obstructive pulmonary disease: Qualitative study [Internet]. 2019;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85070540885&partnerID=MN8TOARS

Pages